Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
5T4 inhibitor
DRUG CLASS:
5T4 inhibitor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
YH38560 (2)
ALG.APV-527 (1)
Anti-5T4 CAR-NK Cell Therapy (0)
CBA-1535 (0)
GEN1044 (0)
IBR854 (0)
MVA 5T4 (0)
YH38560 (2)
ALG.APV-527 (1)
Anti-5T4 CAR-NK Cell Therapy (0)
CBA-1535 (0)
GEN1044 (0)
IBR854 (0)
MVA 5T4 (0)
›
Associations
(3)
News
Trials
Phase
Status
Apply
Phase
Status
Apply
Study of Anti-5T4 CAR-raNK Cell Therapy in Locally Advanced or Metastatic Solid Tumors (NCT05137275)
Phase 1
Shanghai East Hospital
Shanghai East Hospital
Recruiting
Phase 1
Shanghai East Hospital
Recruiting
Last update posted :
10/27/2022
Initiation :
11/24/2021
Primary completion :
04/01/2023
Completion :
05/01/2023
HER-2 • ER • ALK • PGR • IL6 • CD4 • IL2 • NCAM1 • IL10
|
EGFR mutation
|
IBR854
Study of Anti-5T4 CAR-NK Cell Therapy in Advanced Solid Tumors (NCT05194709)
Phase 1
Wuxi People's Hospital
Wuxi People's Hospital
Recruiting
Phase 1
Wuxi People's Hospital
Recruiting
Last update posted :
02/02/2022
Initiation :
12/30/2021
Primary completion :
12/30/2022
Completion :
12/30/2022
IFNG • IL6 • CD4 • IL2 • NCAM1 • IL10 • IL1B • CRP
|
Anti-5T4 CAR-NK Cell Therapy
Safety Study of TroVax Alone vs. TroVax Plus Interferon Alpha in Patients With Renal Cancer (NCT00445523)
Phase 2
The Methodist Hospital Research Institute
The Methodist Hospital Research Institute
Completed
Phase 2
The Methodist Hospital Research Institute
Completed
Last update posted :
03/17/2016
Initiation :
05/01/2006
Primary completion :
01/01/2008
Completion :
02/01/2008
IL2 • IFNA1
|
TroVax (MVA 5T4)
Activity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate Cancer (NCT00448409)
Phase 2
The Methodist Hospital Research Institute
The Methodist Hospital Research Institute
Completed
Phase 2
The Methodist Hospital Research Institute
Completed
Last update posted :
03/17/2016
Initiation :
05/01/2006
Primary completion :
04/01/2007
Completion :
05/01/2007
CSF2
|
Leukine (sargramostim) • TroVax (MVA 5T4)
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login